The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and investment on
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has
Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced statistically significant results on key efficacy endpoints in severe ED patients after a single administration of IPED2015. Moreover, no observations of critical adverse events were recorded.
October 24, 2018 MANCHESTER, ENGLAND Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient
MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
We are delighted to welcome Dr John Connell to MAC who will lead our pharmacodynamic offering. Dr Connell completed his
MAC Clinical Research has recently completed the installation of a state-of-the-art aseptic suite at its flagship research site in Manchester.
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
